Revenue | ₹262.70Cr |
Net Profits | ₹63.58Cr |
Net Profit Margins | 24.20% |
Concord Biotech Ltd’s revenue fell -17.96% since last year same period to ₹262.70Cr in the Q2 2025-2026. On a quarterly growth basis, Concord Biotech Ltd has generated 19.87% jump in its revenue since last 3-months.
Concord Biotech Ltd’s net profit fell -33.59% since last year same period to ₹63.58Cr in the Q2 2025-2026. On a quarterly growth basis, Concord Biotech Ltd has generated 44.3% jump in its net profits since last 3-months.
Concord Biotech Ltd’s net profit margin fell -19.05% since last year same period to 24.20% in the Q2 2025-2026. On a quarterly growth basis, Concord Biotech Ltd has generated 20.39% jumped in its net profit margins since last 3-months.
The revenue for Concord Biotech Ltd in the Q2 results 2025 was ₹262.70Cr.
The net profit for Concord Biotech Ltd in the Q2 results 2025 was ₹63.58Cr.
The net profit margin for Concord Biotech Ltd in the Q2 results 2025 was 24.20%.
The revenue for Concord Biotech Ltd in the Q2 results 2024 was ₹320.21Cr.
The net profit for Concord Biotech Ltd in the Q2 results 2024 was ₹95.74Cr.
The net profit margin for Concord Biotech Ltd in the Q2 results 2024 was 29.90%.